Validus Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALIDUS PHARMS, and what generic alternatives to VALIDUS PHARMS drugs are available?
VALIDUS PHARMS has thirteen approved drugs.
There is one US patent protecting VALIDUS PHARMS drugs.
There is one patent family member on VALIDUS PHARMS drugs in one country and ten supplementary protection certificates in six countries.
Summary for Validus Pharms
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 13 |
Drugs and US Patents for Validus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Validus Pharms | LASIX | furosemide | TABLET;ORAL | 016273-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Validus Pharms | LASIX | furosemide | TABLET;ORAL | 016273-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Validus Pharms | ANZEMET | dolasetron mesylate | INJECTABLE;INJECTION | 020624-002 | Sep 11, 1997 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-003 | Dec 31, 1984 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Validus Pharms | BUMEX | bumetanide | TABLET;ORAL | 018225-003 | Jun 14, 1985 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Validus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Validus Pharms | LOTENSIN HCT | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 020033-001 | May 19, 1992 | 4,410,520*PED | ⤷ Subscribe |
| Validus Pharms | BUMEX | bumetanide | TABLET;ORAL | 018225-001 | Feb 28, 1983 | 3,806,534 | ⤷ Subscribe |
| Validus Pharms | LOTENSIN | benazepril hydrochloride | TABLET;ORAL | 019851-004 | Jun 25, 1991 | 4,410,520*PED | ⤷ Subscribe |
| Validus Pharms | LOTENSIN HCT | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 020033-002 | May 19, 1992 | 4,410,520*PED | ⤷ Subscribe |
| Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-007 | Feb 11, 1982 | 3,454,698 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALIDUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 200 mg and 300 mg | ➤ Subscribe | 2007-08-21 |
| ➤ Subscribe | Extended-release Capsules | 100 mg | ➤ Subscribe | 2014-05-23 |
International Patents for Validus Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2452588 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Validus Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0502314 | SPC/GB02/037 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419 |
| 0502314 | C300095 | Netherlands | ⤷ Subscribe | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
| 0266730 | SPC/GB97/005 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926 |
| 0454511 | SPC/GB99/008 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
| 0480717 | 98C0025 | Belgium | ⤷ Subscribe | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
